Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
The History of Valproate in Clinical Neuroscience
1
x
$
30.00
Early-Life Adversity, CRF Dysregulation, and Vulnerability to Mood and Anxiety Disorders
1
x
$
30.00
Divalproex and Epilepsy
1
x
$
30.00
Before Attributing Catatonia to Autism with Anxiety, All Other Causes should be Carefully Excluded, Especially in a Patient with Meningioma
1
x
$
30.00
View Cart
Checkout
Home
Valproate-Autism Labyrinth
“Before Attributing Catatonia to Autism with Anxiety, All Other Causes should be Carefully Excluded, Especially in a Patient with Meningioma” has been added to your cart.
View cart
Valproate-Autism Labyrinth
$
30.00
Valproate-Autism Labyrinth quantity
Add to cart
Want a discount? Become a member by purchasing
Psychopharmacology Bulletin Subscription - Individual
!
Categories:
Psychopharmacology Bulletin
,
VOL 54 No. 4 Articles – 2024
Tags:
Ahmed Naguy
,
autism
,
folic acid
,
irritability
,
Maryam Alqabandi
,
risk
,
translational model
,
valproate
Description
Description
Clinical Perspective
Valproate-Autism Labyrinth
By Ahmed Naguy, Maryam Alqabandi
Related products
Early-Life Adversity, CRF Dysregulation, and Vulnerability to Mood and Anxiety Disorders
$
30.00
Add to cart
Details
Autism Spectrum Disorder Screening at 18–36 Months in Infants with Moderate and Severe Neonatal Encephalopathy: Is Routine Screening Required? (OPEN ACCESS)
$
0.00
Add to cart
Details
The Efficacy of Divalproex for Partial Epilepsies
$
30.00
Add to cart
Details
Schizophrenia and Valproate
$
30.00
Add to cart
Details
Page load link
Go to Top